An Adaptive, Randomized, Placebo-controlled, Double-blind, Multi-center Study of Oral FT-4202, a Pyruvate Kinase Activator in Patients with Sickle Cell Disease
عنوان الدراسة
An Adaptive, Randomized, Placebo-controlled, Double-blind, Multi-center Study of Oral FT-4202, a Pyruvate Kinase Activator in Patients with Sickle Cell Disease
داعم الدراسة
Forma Therapeutics, Inc
دواء الدراسة
FT-4202
رقم بروتوكول الدراسة
4202-HEM-301
حالة الدراسة
Ongoing
موقع الدراسة
King Khalid University Hospital (Riyadh),Prince Mohammad Bin Naser Hospital, Jizan, Saudi Arabia
مرحلة الدراسة
2/3
Comments and Suggestions
For any inquiries or comments about the government services, please fill in the required information.